$3.870
+0.233 (+6.03%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PSTV Prediction & Forecast by Similar Chart Analysis
Alphio's PSTV stock price prediction model matches the current Plus Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.90 (+0.70%). The 1-week path is $3.96 (+2.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Plus Therapeutics Inc Stock?
PSTV is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some positive company-specific catalysts, but the current technical setup is still weak, there is no Intellectia buy signal, and the analyst target was sharply cut despite a Buy rating. For an impatient investor, this is not a clean entry, so the better call is to hold off rather than buy now.
PSTV stock price ended at $3.87 on Friday, after rising +6.03%
Plus Therapeutics Inc (PSTV) last closed at $3.87, gaining +6.03%. These facts feed the 1-day and 1-week PSTV price prediction above.
Forecast Drivers
Plus Therapeutics Inc (PSTV) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PSTV, ranked by similarity.
Seasonality analysis for PSTV
Historically the probability of a positive August return for PSTV is 0.00%. January offers the highest probability of a positive month at 59.02%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PSTV
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.29 | $0.30 | $0.34 | -92.30% |
| Sep 2026 | $0.17 | $0.23 | $0.27 | -93.98% |
| Oct 2026 | $0.26 | $0.28 | $0.31 | -92.75% |
| Nov 2026 | $0.23 | $0.23 | $0.30 | -93.98% |
| Dec 2026 | $0.27 | $0.30 | $0.31 | -92.19% |
In 2026, Plus Therapeutics Inc (PSTV) is projected to range from $0.17 to $0.34.
Plus Therapeutics Inc 2026 monthly forecast
In Aug 2026, Plus Therapeutics Inc is projected to average $0.30, with a low of $0.29 and high of $0.34.
In Sep 2026, Plus Therapeutics Inc is projected to average $0.23, with a low of $0.17 and high of $0.27.
In Oct 2026, Plus Therapeutics Inc is projected to average $0.28, with a low of $0.26 and high of $0.31.
In Nov 2026, Plus Therapeutics Inc is projected to average $0.23, with a low of $0.23 and high of $0.30.
In Dec 2026, Plus Therapeutics Inc is projected to average $0.30, with a low of $0.27 and high of $0.31.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.